Mustang Bio Investor Relations Material
Latest events
Q2 2025
8 Aug, 2025
Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mustang Bio Inc
Access all reports
Mustang Bio, Inc. is a biotechnology company focused on the development of cell and gene therapies for the treatment of cancer and rare genetic diseases. The company specializes in advancing innovative approaches such as chimeric antigen receptor (CAR) T-cell therapies and gene editing technologies. The company is headquartered in Worcester, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MBIO
Country
🇺🇸 United States